After a long primary season, it appears that the American people will have a choice between Hillary Clinton, the likely Democratic nominee, and Donald Trump, the likely Republican nominee. Despite the relative uniqueness of each candidate, there’s an old proverb that says the only thing we learn from new elections is that we learned nothing from the last one. In the summer of 2016, we once again face an election where the winner may dictate the future of health care in this country. It is important to understand each candidate’s stance on health care.
Clinton also expressed serious concerns about the increase in the number of mergers within in the health care industry, saying that she is “worried that the balance of power is moving too far away from consumers.”
far less money for the country and for the people.”
Also in contrast to Clinton, Trump looks to free market forces to provide cost savings, supporting the federalization of insurance regulation that would allow insurance providers to offer products and services across state lines rather than being regulated, and separated on the state level. Likewise, Trump supports the expansion of Health Savings Accounts (HSAs) so that the health care-buying public’s buying power incentivizes natural price controls and competition among providers and supports allowing full tax deductions for health insurance costs on personal tax returns.
Both candidates state that high drug costs are becoming an unsustainable problem. Clinton supports attacking the problem by providing public incentives to reduce the high costs of research and development of new drugs, allowing the savings to be passed on to the public. Trump, on the other hand, supports competition by allowing international imports of certain drugs to lower overall costs at home.
Hosted at the University of Michigan Detroit Center |
Thursday March 9 2017 |